NCT07550543

Brief Summary

The goal of this clinical trial is to evaluate whether pulsed electromagnetic field (PEMF) therapy delivered via the Super Inductive System (SIS), integrated into a multimodal rehabilitation program, improves pain, function, pressure pain threshold, muscle strength, psychological status, and quality of life in adults with shoulder tendinopathies. The main questions it aims to answer are:

  • Does the addition of PEMF (SIS) therapy reduce pain intensity and improve pressure pain threshold compared to standard balneophysiotherapy?
  • Does PEMF (SIS) therapy improve shoulder function, muscle strength, psychological status, and quality of life? The study will compare a multimodal rehabilitation program supplemented with PEMF (SIS) therapy to standard balneophysiotherapy to determine whether the addition of PEMF (SIS) provides superior clinical outcomes. Participants will:
  • Undergo a multimodal rehabilitation program including balneophysiotherapy
  • Be assigned to receive either standard treatment or treatment supplemented with PEMF (SIS) therapy
  • Be evaluated at baseline (admission), immediately after treatment completion (discharge), and at 4 weeks after treatment using validated clinical instruments assessing pain, function, pressure pain threshold, muscle strength, psychological status, depressive symptoms, and quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Apr 2026Aug 2026

Study Start

First participant enrolled

April 1, 2026

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

April 16, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

Nanopulsed Electromagnetic FieldPulsed Electromagnetic FieldPEMFSuper Inductive SystemBalneotherapyPhysiotherapyShoulder PainTendinopathy

Outcome Measures

Primary Outcomes (1)

  • Pain intensity assessed by Visual Analog Scale (VAS)

    Pain intensity will be measured using the Visual Analog Scale (VAS). Participants were asked to rate their current pain intensity by marking a point on a 100-mm horizontal line, where 0 indicates "no pain" and 100 indicates "worst pain imaginable." The score was recorded in millimeters (mm). Outcome range and interpretation: Minimum value: 0; Maximum value: 100. Higher scores indicate worse pain intensity.

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

Secondary Outcomes (7)

  • Shoulder function assessed by Shoulder Pain and Disability Index (SPADI)

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

  • Pressure Pain Threshold (PPT) assessed by digital algometry

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

  • Range of motion (ROM) assessed by goniometry

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

  • Muscle strength assessed by dynamometry

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

  • Psychological status assessed by Hospital Anxiety and Depression Scale (HADS)

    Baseline, immediately after the 2-week treatment period, and at 1-month follow-up.

  • +2 more secondary outcomes

Study Arms (2)

Balneophysiotherapy plus Nanopulsed Electromagnetic Field Therapy Group

EXPERIMENTAL

Participants in the experimental group receive a standardized balneophysiotherapy program combined with nanopulsed electromagnetic field therapy (Super Inductive System) applied to the affected shoulder, delivered over 10 treatment days at the Balneal and Rehabilitation Sanatorium Techirghiol, Romania.

Device: Nanopulsed Electromagnetic Field Therapy (SIS)

Balneophysiotherapy Control Group

ACTIVE COMPARATOR

Participants allocated to the control group receive a structured two-week rehabilitation program comprising balneophysiotherapy interventions at the Balneal and Rehabilitation Sanatorium Techirghiol, Romania.

Other: Balneophysiotherapy

Interventions

The intervention is based on the region's specific natural therapeutic resources and is conducted under continuous medical supervision. The treatment program includes saline therapeutic baths combined with exercise therapy and applications of sapropelic therapeutic mud, administered daily over a two-week period, five days per week. In addition, patients receive electrotherapy according to a standardized protocol, including magnetotherapy, interferential current therapy, and therapeutic ultrasound. The rehabilitation program also incorporates massage therapy and individualized therapeutic exercises.

Balneophysiotherapy Control Group

Nanopulsed electromagnetic field therapy is delivered using the Super Inductive System (SIS) device applied to the affected shoulder. The intervention is administered daily over a two-week period, with a total of 10 sessions. Each session lasts approximately 10-15 minutes. The therapy delivers high-intensity electromagnetic pulses with adjustable frequency and intensity, aiming to reduce pain, stimulate tissue regeneration, and improve functional outcomes.

Balneophysiotherapy plus Nanopulsed Electromagnetic Field Therapy Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged between 18 and 70 years.
  • Patients with chronic shoulder pain lasting more than 3 months, of non-traumatic origin, persistent despite prior conservative treatment.
  • Clinical diagnosis of shoulder tendinopathy and/or subacromial pain syndrome based on medical history and physical examination.
  • Presence of shoulder pain and functional limitation confirmed by clinical assessment and baseline functional evaluation (SPADI).
  • Ability to comply with the treatment protocol and attend scheduled follow-up assessments.
  • Provision of written informed consent prior to participation.

You may not qualify if:

  • Full-thickness rotator cuff tears with surgical indication.
  • Recent major shoulder trauma (within the last 6 months).
  • Active systemic inflammatory or rheumatologic diseases.
  • Presence of metallic implants in the treatment area or implanted electronic devices (e.g., pacemaker).
  • Neurological disorders affecting the upper limb.
  • Contraindications to balneotherapy (e.g., severe cardiovascular disease, renal failure, severe dermatological conditions).
  • Decompensated chronic diseases at the time of enrollment (cardiovascular, hepatic, renal, respiratory, or neurological).
  • Skin lesions at the site of treatment application.
  • Pregnancy or breastfeeding.
  • Active neoplastic disease.
  • Decompensated psychiatric disorders.
  • History of hypersensitivity to natural therapeutic factors used in balneotherapy.
  • Refusal to participate or inability to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Balneal and Rehabilitation Sanatorium of Techirghiol

Constanța, Techirghiol, 906100, Romania

RECRUITING

MeSH Terms

Conditions

Shoulder PainTendinopathy

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesTendon InjuriesWounds and Injuries

Central Study Contacts

Alexandra E Ciota, PhD Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (Associate) Dr. Ionescu Elena-Valentina

Study Record Dates

First Submitted

April 16, 2026

First Posted

April 24, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations